Insights - BIO

Areas of Work

	BIO Supports Administration’s Effort to Devise Pandemic Influenza Plan Nov 1 2005 WASHINGTON, D.C. (November 1, 2005) – Jim Greenwood, president and CEO of the Biotechnology Industry Organization, issued the following statement today in response to the National Pandemic...
	BIO InvestorForum and Personalized Medicine Conference Attract Record Crowds Oct 20 2005 SAN FRANCISCO (October 20, 2005) – The BIO InvestorForum concluded here today with record attendance from the investment community, industry executives and the media. The conference was hosted...
	CMS Administrator, Greenwood Available for Press Interviews Oct 19 2005 SAN FRANCISCO (October 19, 2005) – Mark McClellan, administrator for the Centers for Medicare and Medicaid Services (CMS), and Jim Greenwood, president of the Biotechnology Industry Organization...
	BIO Supports Santorum/Hart Bill to Amend Tax Law Oct 19 2005 WASHINGTON, D.C. (October 19, 2005) – Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), issued the following statement supporting legislation introduced today by...
	Pain, Cancer, Diabetes, Hepatitis C and Lupus Among the Growth Focus Topics for BIO InvestorForum Panel Discussions Oct 12 2005 WASHINGTON, D.C. (October 12, 2005) – Therapeutic workshops slated for the BIO InvestorForum will feature a cross-section of experts in disease areas poised for growth in research and financing...
	Former HHS Secretary Thompson to Headline BIO/Burrill Personalized Medicine Event Sep 27 2005 WASHINGTON, D.C. (September 27, 2005) – Tommy Thompson, former secretary of the U.S. Department of Health and Human Services, will deliver a keynote address Tuesday, Oct 18, 2005 in San...
	Statement by BIO President & CEO Jim Greenwood on New Acting FDA Commissioner Dr. Andrew von Eschenbach Sep 23 2005 WASHINGTON, D.C. (September 23, 2005) -- The Hon. James C. Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), released the following statement regarding today’s...
	BIO President Jim Greenwood Asks NYSE to Reconsider Decision on Life Sciences Research Sep 14 2005 WASHINGTON, D.C. (September 14, 2005) -- On September 7, the New York Stock Exchange (NYSE) postponed the listing of Life Sciences Research (Huntingdon Life Science) in an apparent reaction to...
	BIO’s Rob Chess to Testify on Patent Issue Sep 14 2005 WASHINGTON, D.C. (September 14, 2005) – Robert B. Chess, executive chairman of San Carlos, Calif.-based Nektar Therapeutics, will testify Thursday before the House Judiciary Subcommittee on...
	Biotechnology Industry Organization Presents Leadership Award to Missouri Governor Sep 13 2005 ST. LOUIS, MO (September 13, 2005) -- The Biotechnology Industry Organization (BIO) today presented an “Award for Leadership Excellence” to Missouri Gov. Matt Blunt, recognizing his support of...